AGO-OVAR23/DUO-O

Trial Description: 
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib
Lead Cooperative Group: 
Disease Site: 
Ovarian
Trial Status: 
Recruiting
Contact person: